HSV and CIOM outcomes
Herpes simplex
VIRUS, HERPES SIMPLEX, ORAL MUCOSITIS
Among 54 randomized patients, the incidence of CIOM was 16.0% (4 out of 25 patients) and 58.6% (17 out of 29 patients) in the study group and the control group, respectively (P = 0.001; Table 
Herpes simplex virus reactivation and chemotherapy-induced oral mucositis outcomes: Intent-to-treat analysis (N = 54)
Herpes simplex virus reactivation and chemotherapy-induced oral mucositis outcomes: Per-protocol analysis (N = 49)